[Image courtesy of iStock]
Determining patient eligibility is one of the most time-intensive and expensive processes in clinical trials. Not only do traditional practices include gathering detailed, paper-based patient information to determine if a patient is eligible to participate, but outdated tracking systems are prone to costly errors. But a significant shift is underway as inclusion and exclusion criteria become more complex and clinical trial sites span the globe. Trial sponsors now recognize that decades-old methods for eligibility screening are no longer feasible, making the shift to a centralized, digital platform for collecting and managing this data essential to keeping today’s multi-faceted studies on track. Acknowledging eligibility’s inherent cost and complexityThe eligibility screening process is a critical step in the success of any trial, not only to enroll qualified subjects to ensure new d…